BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 1999
View Archived Issues
Vancomycin-tolerant S. pneumoniae detected and analyzed
Read More
Delta-opioid receptor activation as preconditioning, similar to natural hibernation
Read More
Zanamivir shows promise in influenza prevention
Read More
Mallinckrodt and SmithKline Beecham sign copromotion agreement for ADHD drug
Read More
Patient enrollment completed in study of shortened Targis treatment for BPH
Read More
Digital Gene Technologies and Recordati reach milestone in atherosclerosis agreement
Read More
Connetics enters licensing and development agreement with Paladin for ConXn
Read More
AxyS Pharmaceuticals forms new subsidiary
Read More
Company Profile: Maret
Read More
BTG acquires novel technology for treatment of HIV
Read More
Clinical trials commence for two new Eisai compounds
Read More
Allergan ciclosporin NDA up for review this month by advisory committee
Read More
New orally bioavailable salt of ET antagonist prepared by SmithKline Beecham
Read More
Antitumor and antibacterial compound isolated from cultures of Streptomyces at Kyowa Hakko
Read More
Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal
Read More
Human Genome Sciences discovery may lead to novel immunotherapies and vaccines
Read More
P2X7 receptor antagonists described in recent patent literature
Read More
Aromatic hydrazones from Uniroyal with anti-HIV-1 activity encompassing mutant strains
Read More
Anti-CD154 antibody facilitates islet allograft survival in highly relevant preclinical model
Read More
Potential of cerebrocrast in diabetes suggested by animal data
Read More
INO-5042: new agent for venous insufficiency proves effective in various animal models
Read More
Orphan Medical, Pierre Fabre sign letter of intent to license Busulfex
Read More
CAT gets U.K. approval to begin phase II trials of novel glaucoma treatment
Read More
Johns Hopkins team identifies unusually promising new treatment for ALS
Read More
E.U.-wide approval obtained for Ziagen
Read More
Inhibitors of P. carinii and T. gondii DHFR developed at U.S. universities
Read More
Allelix characterizes first-generation NGF receptor antagonist with antiallodynic properties
Read More
Rapamune up for FDA advisory committee review in late July
Read More
